Quick Order Cart

Cat. No. ARG42594

CAT Knockout MES-OV Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Ovary

  • Disease:

    Ovarian serous cystadenocarcinoma

The CAT Knockout MES-OV Polyclonal Cells are a CRISPR/Cas9-edited polyclonal cell population with disruption of CAT in the MES-OV ovarian clear cell carcinoma line. Catalase decomposes hydrogen peroxide, protecting cells from oxidative stress; its expression is regulated by NRF2 and FOXO3, and it functions in concert with SOD1 and SOD2. This knockout model provides a powerful tool to investigate redox imbalance, hydrogen peroxide-mediated signaling, and antioxidant defense coordination in ovarian cancer. Researchers can perform catalase activity assays, intracellular ROS detection, cell viability studies under oxidative stress, and evaluate compensatory pathway activation.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    MES-OV

    Sex of Donor

    Female

    Age

    53 years

    Derived From Site

    Ascites

    Gene Name

    CAT

    Gene Identifier

    NCBI Gene ID 847

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    McCoy's 5A

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CAT Knockout MES-OV Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population with targeted disruption of the CAT gene in MES-OV cells. This loss-of-function model enables investigation of catalase biology in human ovarian clear cell carcinoma. The polyclonal composition captures diverse genetic alterations, supporting robust functional and pharmacological studies of oxidative stress defense and redox-regulated pathways.

The MES-OV cell line originates from human ovarian clear cell carcinoma, an epithelial malignancy characterized by distinctive genetic and metabolic alterations, including dysregulation of oxidative stress responses. It retains key tumor properties, providing a highly relevant model for dissecting ovarian cancer biology, evaluating drug sensitivity, and identifying novel therapeutic targets.

Catalase (CAT) is a peroxisomal enzyme that efficiently decomposes hydrogen peroxide into water and oxygen, critically shielding cells from oxidative injury. Its expression is transcriptionally governed by NRF2 (NFE2L2), FOXO3, NF-??B, HIF1A, and PPARG, which respond to cellular redox status. Catalase activity directly modulates intracellular hydrogen peroxide levels and redox-sensitive signaling cascades involving superoxide dismutases SOD1 and SOD2, peroxiredoxin PRDX1, and glutathione peroxidase GPX1. Peroxisomal import requires interaction with PEX5, and function is integrated with the thioredoxin system (TXN, TXNRD1). Thus, CAT occupies a central position in antioxidant defense and redox signal transduction.

In MES-OV ovarian carcinoma cells, catalase neutralizes endogenous metabolic hydrogen peroxide and oxidative stress induced by chemotherapeutics. CAT knockout leads to hydrogen peroxide accumulation, redox imbalance, and potential activation of stress-responsive transcription factors. This model facilitates study of ovarian cancer cell adaptation to oxidative damage, effects on proliferation and apoptosis, and treatment resistance mechanisms. Crosstalk between catalase loss and complementary antioxidant systems, such as glutathione and thioredoxin pathways, can be systematically examined.

The polyclonal knockout pool supports diverse investigations: hydrogen peroxide signaling in tumor progression, antioxidant defense coordination, and oxidative stress-induced senescence. Standard assays include catalase immunoblotting, enzyme activity measurement, Amplex Red hydrogen peroxide quantification, and flow cytometric ROS detection with DCFH-DA. Immunofluorescence examines peroxisomal protein localization, while cell viability under oxidative challenge provides functional readouts. RT-qPCR reveals compensatory transcriptional responses. For technical assistance and ordering details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)